FindTrial
Sign In

Paclitaxel, Cisplatin

DRUG7 trials

Sponsors

Indira Gandhi Medical College, Shimla, RenJi Hospital, Sun Yat-sen University, Henan Cancer Hospital, Chongqing University Cancer Hospital

Conditions

Adjuvant ChemotherapyCarcinoma CervixCervical CancerEsophageal Squamous Cell CarcinomaInvasive Duct Carcinoma of BreastLocally Advanced Esophageal Squamous Cell CarcinomaLymph Node MetastasesMucinous Breast Cancer

Phase 2

Combination of Tislelizumab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-002)
Active, not recruitingNCT05520619
Sun Yat-sen UniversityEsophageal Squamous Cell Carcinoma, Locally Advanced Esophageal Squamous Cell Carcinoma
Start: 2022-09-15End: 2026-07-31Target: 114Updated: 2024-11-18
BTLA Inhibitor (JS004) Combined with Toripalimab and Chemotherapy in the Perioperative Treatment of Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
Not yet recruitingNCT06588335
Henan Provincial People's HospitalEsophageal Squamous Cell Carcinoma
Start: 2024-09-30End: 2026-09-30Target: 20Updated: 2024-09-19

Phase 3

Concurrent Chemoradiotherapy With Weekly Cisplatin Versus Concurrent Chemoradiotherapy With Weekly Cisplatin and Paclitaxel in Locally Advanced Carcinoma Cervix
NCT01593306
Indira Gandhi Medical College, ShimlaCarcinoma Cervix
Start: 2011-07-31End: 2013-02-28Target: 80Updated: 2012-05-08
Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women
RecruitingNCT03201861
RenJi HospitalInvasive Duct Carcinoma of Breast, Mucinous Breast Cancer, Tubular Breast Cancer
Start: 2017-07-27End: 2027-12-31Target: 762Updated: 2025-05-16
A Trial Comparing Adjuvant Chemotherapy With Observation After Concurrent Chemoradiotherapy of Cervical Cancer (With Pelvic or Para-aortic Node Involvement)
NCT03468010
Sun Yat-sen UniversityAdjuvant Chemotherapy, Cervical Cancer, Lymph Node Metastases +1
Start: 2018-03-01End: 2025-03-01Target: 432Updated: 2018-03-26
Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy for Resectable Locally Advanced Esophageal Cancer (HCHTOG1903)
RecruitingNCT04138212
Henan Cancer HospitalEsophageal Squamous Cell Carcinoma
Start: 2019-10-22End: 2028-12-21Target: 456Updated: 2022-08-09

Unknown Phase

The Efficacy of Adjuvant Chemotherapy in Locally Advanced Cervical Cancer
RecruitingNCT04409860
Chongqing University Cancer HospitalCervical Cancer
Start: 2020-05-26End: 2029-04-30Target: 120Updated: 2023-04-11

Related Papers

Long-term survival and post-hoc analysis of toripalimab plus definitive chemoradiotherapy for oesophageal squamous cell carcinoma: insights from the EC-CRT-001 phase II trial.
2024-08-304 citations
EPV068/#398 Randomized controlled trial of the efficacy of adjuvant chemotherapy in patients with residual lesions after concurrent chemoradiation therapy for locally advanced cervical cancer (CQGOG0102)
E-Posters2021-11-01
HPV Sequencing Facilitates Ultrasensitive Detection of HPV Circulating Tumor DNA.
2021-09-2765 citations
Clinical evidence for association of neoadjuvant chemotherapy or chemoradiotherapy with efficacy and safety in patients with resectable esophageal carcinoma (NewEC study).
2020-06-2718 citations
Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinoma: a single-Centre, open-label, randomized, controlled, clinical trial (HCHTOG1903).
2020-04-1512 citations
Prospective randomized study comparing concomitant chemoradiotherapy using weekly cisplatin & paclitaxel versus weekly cisplatin in locally advanced carcinoma cervix.
2016-02-016 citations